• Skip to main navigation
  • Skip to search
  • Skip to main content
University Medical Center Utrecht Home University Medical Center Utrecht Logo
  • Help & FAQ
  • Home
  • Profiles
  • Research units
  • Research output
  • Activities
  • Prizes
  • Press/Media
No photo of Jan Winkel van de

View Scopus Profile

Jan van de Winkel

prof. dr.

  • Division Laboratories and Pharmacy, Center for Translational Immunology (CTI)
  • Infection & Immunity
    19932014

    Research activity per year

    • Overview
    • Network
    • Research output (254)
    • Similar Profiles (1)
    • Supervised Work (23)

    Research output

    • 237 Article
    • 9 Chapter
    • 2 Meeting Abstract
    • 2 Review article
    • More
      • 1 Book editing
      • 1 Abstract
      • 1 Poster
      • 1 Comment/Letter to the editor

    Research output per year

    Research output per year

    • Complement is activated by IgG hexamers assembled at the cell surface.

      Diebolder, C. A., Beurskens, F. J. M., de Jong, R. N., Koning, R. I., Strumane, K., Lindorfer, M. A., Voorhorst, M. M., Ugurlar, D., Rosati, S., Heck, A. J. R., van de Winkel, J. G. J., Wilson, I. A., Koster, A. J., Taylor, R. P., Saphire, E. O., Burton, D. R., Schuurman, J., Gros, P. & Parren, P. W. H. I., 2014, In: Science. 343, 6176, p. 1260-1263 4 p.

      Research output: Contribution to journal › Article › Academic › peer-review

    • Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange.

      Labrijn, A. F., Meesters, J., Goeij, B. E., van den Bremer, E. T. J., Neijssen, J., van Kampen, M. D., Strumane, K., Verploegen, S., Kundu, A., Gramer, M. J., van Berkel, P. H. C., van de Winkel, J. G. J., Schuurman, J. & Parren, P. W. H. I., 2013, In: Proceedings of the National Academy of Sciences of the United States of America. 110, 13, p. 5145-5150 6 p.

      Research output: Contribution to journal › Article › Academic › peer-review

    • IgA EGFR antibodies mediate tumour killing in vivo.

      Boross, P., Lohse, S., Nederend, M., Jansen, J. H. M., van Tetering, G., Dechant, M., Peipp, M., Royle, L., Liew, L. P., Boon, L., van Rooijen, N., Bleeker, W. K., Parren, P., van de Winkel, J. G. J., Valerius, T. & Leusen, J. H. W., 2013, In: Embo Molecular Medicine. 5, 8, p. 1213-1216 4 p.

      Research output: Contribution to journal › Article › Academic › peer-review

    • Staphylococcus aureus formyl peptide receptor-like 1 inhibitor (FLIPr) and its homologue FLIPr-like are potent FcγR antagonists that inhibit IgG-mediated effector functions

      Stemerding, A. M., Kohl, J., Pandey, M. K., Kuipers, A., Leusen, J. H. W., Boross, P., Nederend, M., Vidarsson, G., Weersink, A. J. L., van de Winkel, J. G. J., van Kessel, C. P. M. & van Strijp, J. A. G., 2013, In: Journal of Immunology. 191, 1, p. 353-362 10 p.

      Research output: Contribution to journal › Article › Academic › peer-review

    • The novel tribody [(CD20)(2)xCD16] efficiently triggers effector cell-mediated lysis of malignant B cells.

      Glorius, P., Baerenwaldt, A., Kellner, C., Staudinger, M., Dechant, M., Stauch, M., Beurskens, F. J., Parren, P. W. H. I., van de Winkel, J. G. J., Valerius, T., Humpe, A., Repp, R., Gramatzki, M., Nimmerjahn, F. & Peipp, M., 2013, In: Leukemia. 27, 1, p. 190-201 12 p.

      Research output: Contribution to journal › Article › Academic › peer-review

    View all 254 research outputs

    Powered by Pure, Scopus & Elsevier Fingerprint Engine™

    All content on this site: Copyright © 2025 University Medical Center Utrecht, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply

    We use cookies to help provide and enhance our service and tailor content. By continuing you agree to the use of cookies

    Log in to Pure

    About web accessibility

    Report vulnerability

    Contact us